1StickC,Frederiksen M.Drug therapy in pregnant and nursing women. Principles of Clinical Pharmacology[M] .New York:Academic Press,2001: 277-291.
2E. Thervet,L. Chatenoud,C. Legendre,et al. Clinical significance of T cell monitoring during antithymocyte globulin induction in renal transplantation[J].Transplant Proceed,1997,29(5):2330-2331.
3Gnttiieb S. Serious adverse events associated with perinatal drugs [ J ]. BMJ,2002,325 ( 7373 ) : 1132.
4Maim H,Martikainen J, Klau kka T, et al. Prescription of hazardous drugs during pregnancy [ J ]. Drug Safety,2004,27 ( 12 ) : 899-908.
5Della-Giustina K, Chow G. Medications in pgnancy and lactation [ J ]. Enverger Med Clin North A m, 2003,21 : 585 -6 13.
6Zhu X, Qi X. Pattern of drug use during the first trimester among Chinese women: Data from a population-based cohort study. Europe- an Journal of Clinical[ J]. Pharmacology,2010, 66 (5) :511-518.
7Thervet E, Chatenoud L, Legendre C ,et al. Clinical significance of T cell monitoring during antithymocyte globulin induction in renal trans- plantation[ J]. Transplant Proceed, 1997,29(5 ) :2330-2331.
8山丹.孕期与哺乳期用药指南[M].第2版.北京:科学出版社,2010:11-13.
9杨慧霞,段涛.妊娠期与哺乳期用药[M].第7版.北京:人民卫生出版社,2008.5-6.
10Della-Giustina K, Chow G. Medications in pregnancy and lactation [J]. Emerg Med Clin North Am,2003,21:585-613.
